Tyligand Bioscience
Shanghai
About Tyligand Bioscience
Tyligand Bioscience is a biotechnology company that focuses on the discovery and development of small molecule therapeutics to help patients with cancer and autoimmune diseases. Tyligand's pharmaceuticals are designed to target and treat tumors and autoimmune disorders, enabling healthcare professionals to prescribe more effective medicine and improve health outcomes.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Funding stage: Early Stage Venture
- Last round: Series A (Jul 2023)
- Website: tyligand.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical
Canonical: https://fsome.com/organization/tyligand-bioscience-2418157 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.